Bioxcel TherapeuticsBTAIQ
13F holders, Q3 2025 (September 30)At the end of Q3 2025, 35 institutions reported holding Bioxcel Therapeutics Inc. (BTAIQ) in their 13F filings, unchanged from Q2 2025. 9 opened new positions and 9 sold out. The largest holders were Millennium Management ($2.6M), Oaktree Capital Management ($617K) and FMR LLC ($508K). 2 famous investors held it, including Howard Marks (0.0% of Oaktree Capital Management's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Bioxcel Therapeutics Inc.
- CUSIP
- 09075P204
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $3.5M |
| Exits | 9 | $201K |
All 13F filers, Q2 2025 → Q3 2025: 1,852,065 shares bought and 112,303 shares sold, net +1,739,762 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 35 holders
| Millennium Management | 0.00% | New | 1,028,053 | $2.6M |
| Oaktree Capital Management | 0.01% | No change | 241,188 | $617K |
| FMR LLC | 0.00% | New | 198,600 | $508K |
| Vanguard Group Inc. | 0.00% | Add +920.6% | 192,125 | $492K |
| Geode Capital Management, LLC | 0.00% | Add +344.4% | 125,240 | $321K |
| XTX Topco Ltd | 0.02% | Add +384.0% | 113,364 | $290K |
| BlackRock, Inc. | 0.00% | Add +374.1% | 84,282 | $216K |
| State Street Corp. | 0.00% | New | 52,718 | $135K |
| UBS Group AG | 0.00% | Add +9.2% | 43,542 | $111K |
| Oaktree Fund Advisors, LLC | 0.20% | No change | 42,913 | $110K |
| Jones Financial Companies LLLP | 0.00% | Add +38.5% | 36,000 | $97K |
| Northern Trust Corp. | 0.00% | New | 37,733 | $97K |
| HighTower Advisors, LLC | 0.00% | Add +42.3% | 35,000 | $90K |
| Foundations Investment Advisors, LLC | 0.00% | New | 29,549 | $76K |
| SLT Holdings LLC | 0.05% | New | 29,500 | $76K |
| Osaic Holdings, Inc. | 0.00% | Add +198.5% | 15,083 | $61K |
| Wells Fargo & Company | 0.00% | Reduce -3.6% | 16,316 | $42K |
| Diversify Wealth Management, LLC | 0.00% | No change | 15,000 | $29K |
| Bank of America Corp. | 0.00% | Add +344.8% | 6,881 | $18K |
| IFP Advisors, Inc | 0.00% | New | 4,370 | $11K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +187.1% | 3,933 | $10K |
| Group One Trading LLC | 0.00% | Add +76.7% | 2,249 | $6K |
| Morgan Stanley | 0.00% | Add +3.9% | 1,641 | $4K |
| NewEdge Advisors, LLC | 0.00% | Add +4193.6% | 1,331 | $3K |
| Citigroup Inc. | 0.00% | New | 355 | $909 |
| AllSquare Wealth Management LLC | 0.00% | No change | 175 | $448 |
| SBI Securities Co., Ltd. | 0.00% | Reduce -80.8% | 169 | $433 |
| Washington Trust Advisors, Inc. | 0.00% | No change | 160 | $410 |
| Parkside Financial Bank & Trust | 0.00% | No change | 112 | $287 |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0.00% | No change | 103 | $264 |
| EverSource Wealth Advisors, LLC | 0.00% | New | 60 | $154 |
| JPMorgan Chase & Co. | 0.00% | No change | 45 | $115 |
| BNP Paribas Financial Markets | 0.00% | Reduce -11.4% | 39 | $100 |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 21 | $54 |
| US Bancorp \de | 0.00% | No change | 1 | $3 |
"% of holder's portfolio" is BTAIQ's weight in each manager's 13F, not the share of Bioxcel Therapeutics Inc. the manager owns.